Bill Conlan
Chief Executive Officer
About
Your Mission Is Our Mission: To Achieve the
Best Outcomes at the Lowest Cost.
Bill has 25 years-experience as an entrepreneur with a history of employing the latest technologies to meet challenges in health care. Most recently, Bill co-founded HealthQx, a value-based payment analytics company relied on by payers with 65 million total members. HealthQx was acquired by McKesson in 2016, and renamed Change Healthcare. Previously, Bill founded Healthcare Data Management (HDM), a pioneer in modeling employee health benefit plans and using data-driven metrics to monitor health plan spend. HDM was acquired by Thomson Reuters in 2010 and is now part of IBM Watson. CrossBridge is a mission for Bill, who has ankylosing spondylitis. He also has family members with rheumatoid arthritis and multiple sclerosis
Courtney is a seasoned executive with deep product development, marketing, and strategy experience in SaaS healthcare data and analytic businesses. Courtney’s experience spans multiple industries from his time in strategic consulting, but his primary focus for the last 20 years has been building healthcare data and analytic products and businesses. He has deep experience across the healthcare continuum from his senior roles including Truven Health Analytics (now IBM/Watson), iVantage Health Analytics, Decision Resources Group (now Clarivate), and MMIT. Mr. Morris’s experience and passion for value analytics is well-suited for CrossBridge’s mission of bringing value-based treatment and reimbursement models to specialty chronic care. Courtney enjoys backcountry skiing and is an instrument-rated pilot and can get easily sidetracked talking about either.
Bruce is skilled in clinical research and medical affairs, with expertise in Rheumatology, Dermatology, Endocrinology and Neuro-psychiatry. Dr. Freundlich was Senior Vice president, Medical at Antares Pharmaceuticals and Vice President Inflammation and Vice President, Global Medical Affairs at Pfizer Pharmaceuticals over a nine-year period. Among other accomplishments, he was responsible for bringing Enbrel to market. Dr. Freundlich also served as Chief of Clinical Rheumatology at the University of Pennsylvania for more than six years. Professor of Medicine and alumnus, University of Pennsylvania. MBA at University Massachusetts, Amherst.
Desislava has over 20 years experience in product management and development with a focus on healthcare IT. She has successfully planned, defined and led the implementation of complex integration solutions for HealthQx, SAP, InterComponentWare. She leads a cross-functional product team to develop detailed product plans including technology development and roll-out strategy, to ensure products meets market needs. Desislava earned a M.Sci. Business Informatics, Georg-August-University, Germany and M.Sci. International Economics, University of National & World Economics, Bulgaria.
Larry brings more than 20 years of experience leading the delivery of high-impact technology, M&A integration, and global service solutions. Larry has held several senior technology roles and has spent the better part of the last ten years at Kenexa Technologies where he acted as their Vice President of IT through their global expansion and acquisition to IBM. Throughout Larry’s career, he has provided strategic vision and leadership for developing and implementing information technology initiatives that aligned with aggressive growth strategies.